Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions

Journal of Cancer
Sheng ZhangYanlei Ma

Abstract

The initiation and progression of colorectal cancer (CRC) involves genetic and epigenetic alterations influenced by dietary and environmental factors. Increasing evidence has linked the intestinal microbiota and colorectal cancer. More recently, Fusobacterium nucleatum (Fn), an opportunistic commensal anaerobe in the oral cavity, has been associated with CRC. Several research teams have reported an overabundance of Fn in human CRC and have elucidated the possible mechanisms by which Fn is involved in colorectal carcinogenesis in vitro and in mouse models. However, the mechanisms by which Fn promotes colorectal carcinogenesis remain unclear. To provide new perspectives for early diagnosis, the identification of high risk populations and treatment for colorectal cancer, this review will summarize the relative research progresses regarding the relationship between Fn and colorectal cancer.

Citations

Mar 26, 2019·Expert Review of Molecular Diagnostics·Lili DuanDaiming Fan
Oct 12, 2019·Critical Reviews in Clinical Laboratory Sciences·Erika Hissong, Meredith E Pittman
Jan 12, 2019·Journal of Experimental & Clinical Cancer Research : CR·Sheng ZhangSanjun Cai
Jun 25, 2019·Frontiers in Microbiology·Xiao-Hui ChenYuan Yuan
Aug 2, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Andrew T KunzmannDavid J Hughes
Aug 29, 2019·Metallomics : Integrated Biometal Science·Monika Katarzyna LesiówTeresa Kowalik-Jankowska
Oct 1, 2020·Journal of Experimental & Clinical Cancer Research : CR·Pin GuoYanan Yu
Aug 20, 2019·Oncology Letters·Zhenhua Yang, Guang Ji
Feb 24, 2020·Seminars in Cancer Biology·Wenhao Weng, Ajay Goel
Sep 22, 2019·Microorganisms·Takayuki NambuToshinori Okinaga
Nov 19, 2020·Transplantation Direct·Sanjaya K SatapathyDaniel G Maluf
Jul 3, 2021·Revista de gastroenterología de México·H Cuellar-GómezD A Comoto-Santacruz
Jun 16, 2021·Molecular & Cellular Proteomics : MCP·Keira E MahoneyDonald F Hunt
Jul 28, 2021·Revista De Gastroenterología De México·H Cuellar-GómezD A Comoto-Santacruz

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
PCR
xenografts
xenograft

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.